Nacuity Pharmaceuticals, Inc.
PrivateLast Round
VC Round
Dec 29, 2025
Total Funding Raised
$46.23M
Company Overview
Nacuity Pharmaceuticals, Inc. is a biopharmaceutical company that develops targeted antioxidant therapies for the treatment of ocular diseases and serious chronic conditions involving oxidative stress.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nacuity Pharmaceuticals, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Nacuity Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 29, 2025 | ||||
| Series B | Jun 15, 2022 | ||||
| Series A Extension | Jan 3, 2022 | ||||
| VC Round | Mar 30, 2021 | ||||
| Series A | Jan 24, 2019 | ||||
Series A | Jan 19, 2017 |
Nacuity Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Johns Hopkins Technology Ventures | Series A |
| Tarnagulla Ventures | Series A |
| Foundation Fighting Blindness | Series B, Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 24, 2025
Received designation for investigational therapy NPI-001 tablets.
Nacuity Pharmaceuticals, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nacuity Pharmaceuticals, Inc.'s valuation, stock price, and market status.